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conflation of observational biospecimen research
and clinical care in Latino communities
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Abstract
Background: Expectations of receiving personal health information as a fringe benefit of biospecimen
donation—termed diagnostic misconception—are increasingly documented. We developed an instrument
measuring conflation of observational biospecimen-based research and clinical care for use with Latino
communities, who may be particularly affected by diagnostic misconception due to limited health care access.
Methods: The instrument was developed using prior qualitative research, revised through cognitive interviewing
and expert review, and field tested in a convenience sample of 150 Latino adults in Eastern Washington State. It
was further refined through exploratory factor analysis and validated against existing measures of genetic
knowledge and researcher trust.
Results: The final instrument demonstrated high internal consistency, evidence of content and construct validity, and
no floor and ceiling effects. Individuals who were unemployed, spoke only Spanish, had no health insurance, received
health care outside of traditional venues, and had good self-rated health received higher scores, indicating greater
conflation of biospecimen-based research and clinical care.
Conclusions: The ability to systematically measure beliefs related to diagnostic misconception will help facilitate
ethically-informed efforts to recruit Latinos into biospecimen-based research studies.
Keywords: Hispanic/Latino, Diagnostic misconception, Psychometrics, Measure construction, Biospecimen donation
Background
Observational studies relying on biological samples are
increasingly used to better understand disease with a
goal of improving population health. Though personal-
ized results from biospecimen-based studies are not
often clinically actionable and thus not made available to
participants, prior research indicates that expectations of
receiving meaningful health information as a fringe
benefit of sample donation are not uncommon [1, 2].
Expectations of personal health benefit in the context of
observational research have been termed diagnostic mis-
conception [3], a variant of the therapeutic misconcep-
tion that occurs in clinical trials when research
participants either misunderstand or fail to appreciate
key distinctions between the goals and guiding principles
of research and clinical care [4, 5].
Our research group encountered a number of beliefs
related to diagnostic misconception while conducting a
qualitative study about observational biospecimen-based
research participation with Latinos living on the United
States (US)-Mexico border [6]. Our participants reported
that they were extremely willing to provide biological
samples for research, including blood, urine, stool, saliva,
and buccal cells, but often equated providing a sample
for research with undergoing a clinical evaluation. Sam-
ple donation was described as, ‘…a way of doing our
check-ups to see if we’re in time to [detect] diseases’
([6], p7). The conflation of research and clinical care in-
fluenced participants’ perceptions of the potential benefits
of sample donation, which included receiving individual-
ized information about medical diagnoses and future dis-
ease risk. Additionally, participants had trouble grasping
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the nature of observational research and were more famil-
iar with clinical studies involving medical interventions.
Diagnostic misconception has important ethical di-
mensions, as inaccurate beliefs about the research
process may unduly influence decisions to take part in
research and impact the quality of the informed consent
process [7]. Ethical concerns are magnified for Latino
populations, who face substantial barriers to accessing
health care in the US [8], but are increasingly sought
after as research participants to improve generalizability,
particularly in genomic studies [9, 10]. Factors influen-
cing Latinos’ participation in studies involving the collec-
tion of biologic samples and accompanying phenotypic
information have not been well studied [11, 12]. Whether
expectations of receiving personally meaningful health in-
formation as a fringe benefit of participation drive sample
donation in a coercive manner is particularly unclear.
In an effort to enable identification of beliefs related to
diagnostic misconception in Latino communities, this
study developed and validated a quantitative instrument
measuring conflation of observational biospecimen-
based research and clinical care. The availability of such
an instrument will allow future research exploring the
origins and consequences of diagnostic misconception
and help facilitate ethically-informed recruitment efforts
in medically underserved communities.
Methods
Conceptual model and item development
The conceptual model used to guide instrument devel-
opment was informed by a review of the literature on
biospecimen donation and diagnostic misconception,
prior qualitative research conducted by our group on the
US-Mexico border, and a quantitative measure of thera-
peutic misconception developed by Appelbaum et al.
[13]. Common misconceptions about research with bio-
logical samples that were documented literature or ob-
served in our prior work were grouped into three related
domains. The first domain considers understanding of
the distinctions between observational biospecimen-
based research and clinical trials. The second and third
domains are modeled on dimensions of the therapeutic
misconception scale [13]. Specifically, the second do-
main concerns understanding of the purpose of
biospecimen-based research, i.e. identifies the degree of
conflation of the goals of biological sample collection for
research (creating generalizable knowledge) and the
goals of sample collection in clinical care (informing the
care of the individual patient). The third domain con-
cerns perceptions of the likelihood of receiving personal
benefits in the form of individualized health information
when providing a biospecimen for research.
We developed six items for the first domain and seven
for the second and third. Items were written based on
meaningful themes and quotations from our prior inter-
views and focus groups as well as relevant items devel-
oped for the therapeutic misconception scale [13]. Items
were measured on 4-point Likert-like scales from
strongly agree to strongly disagree. Based on our prior
experience working with Latino communities in Eastern
Washington State, we did not include ‘do not know’ as a
response option because of respondents’ tendency to
choose this option rather than make a potentially incor-
rect guess. Each item’s reading level was assessed in Eng-
lish using the Flesch-Kincaid grade level formula and
kept as low as possible [14]. Items were reviewed for
face-validity in English by two community-based partici-
patory researchers who work extensively with Latino
communities and three experts in measurement devel-
opment. Items were then pre-tested in English (n = 5)
and Spanish (n = 5) with members of the target popula-
tion using standard cognitive interviewing techniques
[15]. Interviews were conducted by a certified translator
trained in cognitive interviewing, who also conducted all
study translations.
Field-testing
The instrument administered for field-testing included
final versions of all items written for each domain along
with single items assessing prior sample donation for re-
search (‘yes’, ‘no’, or ‘don’t know’) and likelihood of pro-
viding a sample for research in the future (‘very likely’,
‘somewhat likely’, or ‘not likely’). We described biological
samples as materials taken from the human body, in-
cluding tissues like skin, hair, nails, or cheek cells and
fluids like blood, urine, or salvia. Scientific research was
described as a method of learning about health and how
to prevent and treat diseases. The definitions were based
on the National Cancer Institutes’ (NCI) Cancer 101
module on biospecimens and biobanking [16]. We also
administered the Genetic Knowledge Index (GKI) [17]
and Hall et al.’s scale measuring trust in medical re-
searchers [18] along with standard demographic and
health care access questions. The five-item version of
the GKI has been previously used to assess basic know-
ledge about genetics in the general population [19]. Par-
ticipants indicated whether five statements were true or false
and a total score from 0 to 5 was calculated from their num-
ber of correct responses (Cronbach’s alpha = 0.56). The 4-
item version of Hall et al.’s scale measuring trust in medical
researchers, which has shown high reliability in national sur-
veys, was modified for administration by removing the ‘do
not know/can’t answer’ response option and changing ‘med-
ical researcher’ to ‘scientists who do research with biological
samples’ and ‘doctor’ to ‘scientist’. The items were measured
on 4-point Likert-like scales from strongly disagree to
strongly agree and summed, with higher overall scores indi-
cating more trust in researchers (Cronbach’s alpha: 0.52).
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We used a targeted recruitment strategy to obtain a
sample of 150 self-identified Latino adults with an
equivalent gender distribution to complete the survey in-
strument. Our sample size was chosen to provide ad-
equate power for exploratory factor analyses (EFA) [20].
Recruitment efforts relied on an NCI Community Net-
works Program Center (CNPC) based in Sunnyside,
Washington with strong connections to the Latino com-
munity there. Latinos living in this area of Eastern
Washington State, called the lower Yakima Valley, are al-
most exclusively from Mexico and are similar to Latinos
living on the border with respect to income, accultur-
ation, education, and health care access [6, 11, 21]. Re-
cruitment and survey administration were conducted by
two CNPC staff members who are residents of the lower
Yakima Valley and fluent in both English and Spanish.
Study participants completed the surveys in person at
community events, CNPC- sponsored health fairs, and
local shopping facilities. Study materials were available
in both English and Spanish and participants could use
whatever language they felt most comfortable with. The
survey was verbally administered, with participants also
having their own copy to read if they desired, and took
approximately 15-20 min to complete. This study was
reviewed by the University of Washington Institutional
Review Board who declared it exempt from ethics ap-
proval. Participants received a $15 gift-card as a thank
your for their time. Completed surveys were periodically
checked by the study team to ensure data quality and
consistency in administration. When recruitment was
completed the survey data was reviewed, coded, and en-
tered into Stata 13 software [22]. A random sample of
surveys (25 %) was reviewed to confirm the quality of
entered data.
Data analysis
Response distributions were examined for each item,
with items coded so that higher scores indicated increas-
ing misconceptions about research with biological sam-
ples. EFA was used to determine if items intended to
measure the same domain were inter-correlated and to
inform item selection for the final instrument [23]. We
used the principal components factor method followed
by Promax rotation, both implemented using the ‘factor’
command in Stata 13. [24, 25]. Promax rotation was
chosen to be consistent with our conceptual model, which
proposed that the three domains were interrelated [26].
In the initial factor extraction, six factors had eigen-
values above one and most items loaded onto the first
factor. The remaining items were spilt so that those asses-
sing accurate and inaccurate perceptions of biospecimen-
based research loaded onto separate factors, suggesting
that the observed factor structure may have been due to
item wording and re-coding. The scree plot test had two
changes in slope or “elbows”, one that occurred after the
third factor and one that occurred after the sixth [27].
Based on these findings, we pursued two models moving
forward. The first retained three factors aligning with the
three domains originally proposed in our conceptual
model. The second model retained one factor and
reflected the overall degree of conflation of biospecimen
research and clinical care. Rotated factor loadings from
these models were used to create two reduced versions of
the instrument (termed the 3-factor and the 1-factor solu-
tions). For both models, items that had loadings above
0.60 on their own factor (and under 0.40 on any other
factor for the 3-factor solution) were included in the
final instrument. A second EFA was conducted on both
reduced instruments and factor loading are reported
for these analyses.
Item-to-scale correlations and Cronbach’s alpha statis-
tics were calculated for both the 1- and 3-factor solu-
tions. Additionally, mean subscores for each dimension
in the 3-factor solution and their correlation with the
total score were calculated along with Cronbach’s alpha
statistics. To assess construct validity correlations with
the GKI and Hall et al.’s scale measuring trust in medical
researchers were examined. In our qualitative work on
the US-Mexico border individuals who knew the least
about research were often the most trusting of re-
searchers and willing to provide biospecimens. Thus, we
hypothesized that increasing misconceptions about
biospecimen-based research as measured by the 3-factor
solution would be negatively correlated with genetic
knowledge and positively correlated with researcher
trust. Subscores for all three domains would follow the
same patterns, with the exception of lay understanding
of research, which would be uncorrelated with re-
searcher trust. Similarly, we hypothesized that increasing
conflation of research with biological samples and clin-
ical care as measured by the 1-factor solution would be
negatively correlated with genetic knowledge and posi-
tively correlated with researcher trust.
Results
Participants
Descriptive characteristics for the cognitive interview
and survey participants are shown in Table 1. Partici-
pants reflected the demographic profile of Latinos living
in the lower YakimaValley, with most having a high school
education or less, an annual household income under
$35,000, and either government health insurance (Medi-
care, Medicaid, or coupons) or no health insurance.
Instrument psychometrics
The 20 piloted items are presented by domain in
Additional file 1: Table S1-S3 included in Additional file 1
along with item-level response data. Missing responses
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were rare and always occurred at the end of each do-
main. Responses in all domains tended to be skewed to-
wards ‘strongly agree’ and ‘agree’, regardless of whether
the item assessed accurate or inaccurate perceptions of
biospecimen research. More than half the respondents
‘agreed’ or ‘strongly agreed’ with 67 % of the lay under-
standing items, 86 % if the purpose items, and 100 % of
the benefits items.
Two of the items were highly skewed and excluded
from the EFA. The Kaiser-Meyer-Olkin (KMO) statistic
for the remaining 18 items was 0.77 and Barlett’s test of
sphericity rejected the null hypothesis, indicating under-
lying data structure sufficient for EFA [26]. Table 2 pro-
vides factor loadings and correlations with domain
scores and total scores for the 8 items retained in the 3-
factor solution. The first factor (benefits) accounted for
33.9 % of item variance, the second factor (purpose)
accounted for 20.3 %, and the third (lay understanding)
accounted for 18.3 %. Items included in the 3-factor so-
lution had high loadings on their own factor and high
correlations with domain scores. But, correlations with
the total score and Cronbach’s alphas were low for the
lay understanding and purpose domains. Alpha statistics
were 0.550 for lay understanding, 0.511 for purpose,
0.808 for benefits, and 0.589 for the overall 8-item scale.
Table 3 provides factor loadings and correlations with
total scores for the 6 items retained in the 1-factor solu-
tion. The first factor accounted for 56.7 % of item vari-
ance and Cronbach’s alpha statistic for the 6-item scale
was 0.844.
Instrument validity
Results for the analyses examining construct validity
are given in Table 4. For the 3-factor solution, purpose
subscores were uncorrelated with genetic knowledge
and negatively correlated with researcher trust, while
total scores were uncorrelated with research trust, con-
tradicting our a priori hypotheses Total scores for the
1-factor solution assessing conflation of biospecimen-
based research and clinical care were negatively corre-
lated with genetic knowledge and positively correlated
with researcher trust as hypothesized.
As the 1-factor solution had superior psychometric
properties and evidence of construct validity, we examined
differences in the degree of conflation of biospecimen-
based research and clinical care by demographic, health
care access, and research participation characteristics
using t-tests and one-way analysis of variance (ANOVA).
These results are presented in Table 5. Conflation of re-
search and clinical care differed significantly by employ-
ment status, primary language spoken, health insurance
type, usual source of health care, and self-rated health.
Individuals who were unemployed, spoke only Spanish,
had no health insurance, received care at non-traditional





Age (Mean, SD) 31.6, 10 38.8,
15
Gender Female 7 75, 50
Employment Full-time 8 68, 45
Part-time 0 30, 20
Unemployed 2 52, 35
Years education ≤4 1 20, 13
5-8 1 39, 26
9-12 2 75, 50
≥13 6 16, 11
Annual household
income
<$15,000 0 63, 42
$15,000 -$34,999 4 71, 47
$35,000 -$49,999 2 13, 9
>$50,000 4 3, 2
Primary language
spoken
Only Spanish 2 38, 25
Spanish better than English 1 36, 24




Only English 0 5, 3
Health insurance Private 7 30, 20
Government 2 77, 51
Both 0 5, 3
None 1 38, 25
Usual source of care Doctor’s office 4 41, 27
Clinic 6 97, 65
Hospital 0 6, 4
Othera 0 6, 4
Has regular doctor Yes 5 112, 75
Self-rated health Excellent or very good 2 51, 34
Good 2 65, 43
Fair or poor 5 34, 23
Don’t know 1 0, 0
Provided a sample for
research in the past
Yes 4 16, 11
No 4 129, 86
Don’t know 2 5, 3
Would provide a sample
for research in the future
Very likely 7 58, 39
Somewhat likely 3 72, 48
Not likely 0 20, 13
Numbers may not sum to 100 due to rounding error
aOther: Pharmacy, traditional medicine/sobadores, family/friends, or prefer not
to answer
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venues, and had good self-rated health received higher
scores, indicating greater conflation of biospecimen-based
research and clinical care. Scores were inversely associated
with years of education (test for linear trend, p-value <
0.008).
Discussion
We successfully developed a 6-item instrument measuring
conflation of observational biospecimen-based research
and clinical care for use in Latino communities. The final
instrument demonstrated high internal consistency, evi-
dence of content and construct validity, and no evidence
of floor and ceiling effects in a convenience sample of 150
Latino adults. It is important to note that the instrument
was developed and field-tested in community samples, not
exclusively with prior biospecimen donors. Diagnostic
misconception can be stringently understood as miscon-
ceptions about the likelihood of receiving personal health-
related information as a part of research participation in
individuals who have provided informed consent and
donated a biological sample [2]. Thus, we believe our
instrument is best described as assessing conflation of
observational biospecimen-based research and clinical
care, not diagnostic misconception. Still, this is one of
the first quantitative instruments with demonstrated re-
liability and validity available to measure beliefs related
to diagnostic misconception in potential biospecimen do-
nors. Documenting the instrument’s performance charac-
teristics in biospecimen donors, who may differ from
potential donors, will allow the instrument to be used at
multiple time-points throughout the research process.
Our conceptual model proposed three domains of mis-
conceptions: lay understanding of the distinction between
Table 2 Final scale characteristics for three-factor solution
Item Mean
(SD)
Factor loadings Correlation with
domain scored
Correlation with
total scored,eBa LUb Pc
1. A person must go to the hospital to give a biological sample for
scientific research.f
2.10 (0.73) 0.710 0.826 0.614
2. A person must be invited by a doctor to give a biological sample for
scientific research.f
2.50 (0.79) 0.860 0.837 0.464
3. Scientific research using biological samples is done to learn about what
causes disease, not about each person who gives a biological sample.
1.89 (0.64) 0.863 0.855 0.047
4. A scientific researcher’s number one goal is to learn more about how
to fight disease.
1.63 (0.54) 0.743 0.784 0.145
5. Researchers will always tell people if their biological sample shows
risk for disease.f
3.01 (0.71) 0.699 0.718 0.561
6. One reason to give a biological sample for scientific research is to
get a medical checkup.f
2.59 (0.76) 0.748 0.790 0.726
7. One reason to give a biological sample for scientific research is to
find out if you have a disease.f
2.91 (0.67) 0.852 0.826 0.645
8. Information you get by giving a biological sample for scientific
research is the best information about your health you could get.f
2.90 (0.76) 0.820 0.854 0.721
Cells empty if <0.400, SD = standard deviation
aBenefits: Mean domain score (SD) = 11.40 (2.32); bLay Understanding: Mean domain score (SD) = 5.09 (1.30); cPurpose: Mean domain score (SD) = 3.52 (0.97);
dPearson product moment; eMean total score (SD) = 20.11 (2.88); fItem reverse coded
Table 3 Final scale characteristics for one-factor solution
Item Mean (SD) Factor loadings Correlation with
total scorea,b
1. A scientific researcher’s number one job is to make sure that the research helps each person
who gives a biological sample.c
2.88 (0.76) 0.647 0.670
2. Researchers mostly do scientific research using biological samples to tell people who give
samples if they are sick.c
2.77 (0.79) 0.773 0.776
3. Researchers will always tell people if their biological sample shows risk for disease.c 3.01 (0.71) 0.654 0.663
4. One reason to give a biological sample for scientific research is to get a medical checkup.c 2.59 (0.76) 0.779 0.774
5. One reason to give a biological sample for scientific research is to find out if you have a disease.c 2.91 (0.67) 0.823 0.806
6. Information you get by giving a biological sample for scientific research is the best information
about your health you could get.c
2.90 (0.76) 0.823 0.811
SD = standard deviation
aPearson product moment; bMean total score (SD) = 17.05 (3.35); cItem reverse coded
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observational biospecimen-based research and clinical tri-
als, understanding of the purpose of biospecimen-based
research, and perceived likelihood of personal benefit.
This model is similar to the theoretical framework used by
Appelbaum et al. to develop their measure of therapeutic
misconception, but with unreasonable beliefs about the
degree of individualization of the intervention replaced by
understanding of the distinction between clinical and ob-
servational research [13]. Our analysis did not confirm the
three domains proposed in our conceptual model. Two
features likely account for the 3-factor solution’s poor
psychometric properties. First, many of the items written
for the ‘purpose’ and ‘lay understanding’ subscales were
dropped due to double loading in the EFA. Thus, these
subscales were comprised of only two items and had poor
internal consistency [28]. Second, respondents’ tendency
to ‘agree’ or ‘strongly agree’ with most items, regardless of
whether they reflected accurate or inaccurate perceptions
of biospecimen-based research, caused response patterns
for these two types of items to vary. That two domains
were comprised of all inaccurate items (lay-understanding
and benefits), while one was comprised of all accurate
items (purpose), also contributed to poor reliability. It is
likely that a multidimensional instrument comprised of all
accurate or all inaccurate items would have had improved
psychometric characteristics. The therapeutic misconcep-
tion scale, for example, contains all inaccurate statements,
despite piloting both accurate and inaccurate items [13]. It
is possible that if we had developed and piloted a larger
number of items for each domain our ability to distinguish
between distinct beliefs related to diagnostic misconcep-
tions would have improved. Alternatively, our conceptual
model may be inaccurate or incomplete. Additional theor-
etical work defining diagnostic misconception and clarify-
ing its manifestation is needed to guide develop of a
multidimensional measure.
Latinos are projected to make up 31 % of the US
population by 2060 [29], but currently lack robust repre-
sentation in clinical research funded by the National In-
stitutes of Health as well as large scale biomarker and
other in vitro studies that use de-identified biological
samples [30, 31]. A growing body of research indicates,
however, that Latinos are highly willing to provide bios-
pecimens for research [11, 12, 32, 33]. Eighty four per-
cent of our sample was ‘very’ or ‘somewhat’ likely to
provide a sample for research in the future. There is
evidence from other populations that individuals may
participate in therapeutic and non-therapeutic research
as way to monitor their health and access otherwise un-
available health services [34, 35]. Thus, concern that
conflation of research participation and clinical evaluation
may drive biospecimen donation in medically underserved
Latino communities was a primary motivation for this
study.
Conflation of biospecimen-based research and clinical
care as measured by our instrument did not differ by
self-reported willingness to participate in biospecimen
research in our sample (p = 0.144). Still, we found that
Latino subgroups facing the most substantial barriers to
accessing high quality health care had higher scores, in-
dicating a greater degree of conflation. Those who were
unemployed, spoke only Spanish, had no health insur-
ance, and received health care outside of traditional
venues were more likely to conflate aspects of research
and clinical care. These groups stand to face a dispro-
portionate burden of the potential harms resulting from
diagnostic misconception, which may include damaged
trust in both doctors and researchers [5].
Efforts to recruit Latinos into biospecimen-based re-
search must avoid paternalism, but also recognizing that
biospecimen donation is not without risk. Additional re-
search is needed to determine whether Latinos’ with lim-
ited access to traditional health care experience undue
influence in the research setting and the role that diag-
nostic misconception plays in this process. While mean
scores did not differ between those who reported prior
biospecimen donation in a one-way ANOVA, individuals
who reported providing a sample for research in the past
tended to have lower scores than those who had not
(15.75 vs. 17.11) and a corresponding non-parametric
Table 4 Validation results
Correlate Coefficient for 3-factor solutiona A priori expectation Coefficient for 1-factor solutiona A priori expectation
Lay understanding GKI -0.300 Yes
Trust -0.002 Yes
Purpose GKI 0.151 No
Trust -0.321 No
Benefits GKI -0.365 Yes
Trust 0.330 Yes
Total Scale GKI -0.361 Yes -0.381 Yes
Trust 0.147 No 0.381 Yes
GKI = Genetic Knowledge Index; Trust = Hall et al.’s scale measuring trusting medical researchers
aPearson product-moment
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test was significant (Kruskal-Wallis p-value < 0.031).
Thus, it is possible the recruitment and informed con-
sent process may help clarify misconceptions about the
purpose and benefits of observational research compared
to clinical care. Alternatively, those with access to research
participation opportunities may be more knowledgeable
about research. These are questions that should be
assessed in future longitudinal studies with biospecimen
donors.
This study had several limitations. We surveyed Mexican-
Americans living in a rural, agricultural community using
non-probability sampling, limiting the generalizability of our
findings to other Hispanic and Latino communities in
the US. A recent focus group study with Puerto Ricans
living in Buffalo, New York with similar income, educa-
tion, and health care access characteristics to our par-
ticipants reported that “the inability to conceptualize
the difference between biomedical research and medical
diagnostic services and results” was common ([32], p465).
This suggests that our results may have broader applicabil-
ity across Latino subpopulations. The instruments used for
validation had poor internal consistency in our population,
which could have affected our results. Additionally, we did
not assess item ordering effects, reproducibility, or re-
sponsiveness of the survey instrument. Our instrument
can be easily implemented in other settings to examine
these properties. Because a gold standard does not exist,
we could not assess criterion validity. Also, because we
did not include a ‘do not know’ option we are unable to
tell if participants misunderstood the question, did now
know enough about research to make an educated guess,
or truly had misperceptions about research with biological
samples. Results from a recent effort to develop a bio-
banking knowledge scale in South Florida suggest that
almost half of respondents respond ‘do not know’ to
knowledge items [36]. Finally, we did not establish the
interpretability of our instrument by assigning qualita-
tive meaning to quantitative scores. Understanding the
degree of conflation that could compromises participa-
tion decision-making and establishing cut-off scores
identifying groups at risk of experiencing diagnostic
misconception during the recruitment and informed
Table 5 Univariate analyses of demographic, health care, and
research participation variables and conflation of research with
biological samples and clinical care
Mean score (SD) p-value
Overall 17.05 (3.35)




Gender Female 16.79 (3.71) 0.341
Male 17.31 (2.95)
Employment Full-time 16.82 (3.25) <0.002
Part-time 15.50 (3.21)
Unemployed 18.25 (3.17)




Annual household income <$15,000 17.06 (2.85) 0.058
$15,000 -$34,999 17.31 (3.61)
$35,000 -$49,999 16.69 (3.15)
>$50,000 12.00 (5.29)








Only English 15.00 (3.16)








Has regular doctor Yes 16.82 (3.42) 0.153
No 17.73 (3.06)




Fair or poor 17.29 (2.05)
Provided a sample for
research in the past
Yes 15.75 (2.49) 0.068
No 17.11 (3.41)
Not sure 19.60 (2.70)
Table 5 Univariate analyses of demographic, health care, and
research participation variables and conflation of research with
biological samples and clinical care (Continued)
Would provide a sample
for research in the future




Not likely 16.25 (2.45)
p-values obtained from independent samples t-test or one-way analysis of
variance using scores from the one factor solution scale
aOther: Pharmacy, traditional medicine/sobadores, family/friends, or prefer not
to answer
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consent process will be an important goal for future
studies.
Conclusions
The availability of a quantitative instrument measuring
conflation of research with biological samples and clinical
care will enable researchers to better flesh out how Lati-
nos make decisions to participate in biospecimen-based
research in a context of health care inequality. The final 6-
item survey instrument can be used to assess baseline
knowledge and beliefs about biospecimen-based research
to guide community engagement activities prior to re-
cruitment or to evaluate educational interventions or
the quality of the informed consent process. Efforts to
improve public health through large-scale biospecimen-
based studies are predicated on investigators’ ability to
engage diverse populations. It is imperative that attempts
to increase Latinos’ representation in population-based
biobanking research do not inadvertently exploit this com-
munity’s limited access to clinical services and desire for
health information [37]. A better understanding of diag-
nostic misconception will help ensure that decisions to
donate biospecimens are made based on an informed
weighing of the current risks and benefits of research
participation.
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